Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
GlobeNewswire

Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

cnbc.com - Elsa Ohlen - Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
CNBC

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track process: preparing for an IPO while…

seekingalpha.com - SA Transcripts - Pharma Mar, S.A. (PHMMF) Shareholder/Analyst Call Transcript
Pharma Mar, S.A. (PHMMF) Shareholder/Analyst Call Transcript
Seeking Alpha

Pharma Mar, S.A. (PHMMF) Shareholder/Analyst Call June 15, 2026 8:00 AM EDT José Martinez-Losa - Head of Capital Markets & Investor Relations Pascal Besman - Senior Vice President of Strategic Development José Antonio…

newsbytesapp.com - Dwaipayan Roy - Why Indian pharma industry is relieved after US-Iran deal
Why Indian pharma industry is relieved after US-Iran deal
NewsBytes

The ongoing war had severely disrupted maritime transit through the Strait of Hormuz, affecting the supply of key petrochemical inputs. The blockade caused a major shortage of propylene, an essential feedstock for producing pharmaceutical-grade…

cyprus-mail.com - Personalization in Pharma marketing: Beyond segments
Personalization in Pharma marketing: Beyond segments
Cyprus Mail

Pharma personalization is about leveraging approved data, content modules, channel signals and consent to shape what a healthcare professional and/or patient audience is going to get next. It is not just a static group like, for example…

prweek.com - Bella Czajkowski - When they arrive at Cannes, pharma companies will be ready to show AI receipts
When they arrive at Cannes, pharma companies will be ready to show AI receipts
US Home

AI will once again be nearly impossible to avoid at the Cannes Lions International Festival of Creativity. Yet this year, simply putting AI in a slide presentation won't cut it. When the advertising industry descends on Cannes from June 22 through…

thehindubusinessline.com - Armenia healthcare scheme opens oncology drug export opportunities for Indian pharma companies
Armenia healthcare scheme opens oncology drug export opportunities for Indian pharma companies
BusinessLine

A new scheme launched by the Republic of Armenia in the healthcare sector has opened up export opportunities for Indian pharma companies in the oncology space. According to Raj Bhanu, Director-General of the Pharmaceutical Export Promotion Council…

benzinga.com - Vandana Singh - Why Is Rhythm Pharma Stock Jumping Today? - Rhythm Pharmaceuticals (NASDAQ:RYTM)
Why Is Rhythm Pharma Stock Jumping Today? - Rhythm Pharmaceuticals (NASDAQ:RYTM)
Benzinga

The six-month data shared on Saturday showed improvements in body mass index, body composition, hyperphagia, and behavioral measures. The company presented the findings at the Endocrine Society's Annual Meeting, ENDO 2026. The trial enrolled 18…

cityam.com - Felix Armstrong - Australian pharma giant Sigma quits Boots takeover talks
Australian pharma giant Sigma quits Boots takeover talks
City AM

Australian pharmacy giant Sigma has walked away from talks over a £7.5bn private takeover of Boots, renewing hopes that the high street pharmacy could float in London. The Australian firm said on Monday that a deal with Boots would not meet…

prweb.com - Moon Rabbit - Moon Rabbit Expands Client Roster and Senior Leadership, Garners More Industry Recognition
Moon Rabbit Expands Client Roster and Senior Leadership, Garners More Industry Recognition
PRWeb

Recent milestones reflecting the agency's continued growth and momentum include: Named strategic/creative agency of record by LEO Pharma, Inc. for SPEVIGO, supporting the brand in the U.S. and globally Named agency of record for a global biotech…

globenewswire.com - Orion Oyj - Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire

STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…

globenewswire.com - France Biotech - France Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 in San Diego
France Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 in San Diego
GlobeNewswire

Meet France Biotech and the French delegation at BIO International Convention 2026 – French Pavilion #3325. France Biotech to Showcase the Strength and Global Momentum of French HealthTech at BIO International Convention 2026 As part of its…

yahoo.com - Lily Mae Lazarus - Exclusive: The researchers who built AI-generated DNA just raised $50 million to reinvent biology
Exclusive: The researchers who built AI-generated DNA just raised $50 million to reinvent biology
Yahoo!

Eric Nguyen was a perpetual student, much to his parents' chagrin. After receiving a master's in engineering at Cornell and doing a stint training AI to interpret and understand the visual world, Nguyen enrolled in a Stanford bioengineering PhD…

globenewswire.com - HMNC Holding GmbH - HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE
HMNC Brain Health announces $50 million first closing of Series B financing and a strategic partnership with MEDICE
GlobeNewswire

Financing will accelerate the development of HMNC's neurosciences portfolio, including Phase 3-readiness activities for Ketabon (KET01) and Nelivabon (BH-200) Agreement grants MEDICE exclusive European commercialization rights for KET01, with…

cnbc.com - Jeff Marks - Salesforce looks to strengthen its AI platform - plus, a positive note for J&J
Salesforce looks to strengthen its AI platform - plus, a positive note for J&J
CNBC

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks climbed on Monday after President Donald Trump announced a…

Receive a Daily briefing on Pharma Industry News

Get Started